Ex-OpenAI science chief Kevin Weil launches Warp Sciences with $215M for drug chemistry
Warp Sciences, co-founded by ex-OpenAI science leader Kevin Weil, launched with $215 million in funding. The startup is establishing a chemistry contract research organization in the US to supply molecules to biotech and pharmaceutical firms. Weil departed OpenAI about six months before the Warp Sciences launch to pursue this opportunity.
Key points
- Founded by Kevin Weil, ex-OpenAI science chief
- $215M funding for drug discovery CRO
- Targets biotech and pharma sector
Summary and key points written by AI from the headline and a short excerpt, so they can be incomplete or wrong. SiliconANGLE did the reporting; read the original for the full story.
Read the full story at SiliconANGLE